Literature DB >> 30364053

The learning curve associated with intracranial angioplasty and stenting: analysis from a single center.

Peiquan Zhou1, Guang Zhang1, Zhiyong Ji1, Shancai Xu1, Huaizhang Shi1.   

Abstract

BACKGROUND: Intracranial angioplasty and stenting is an optional treatment for patients with symptomatic intracranial artery stenosis (IAS) who have failed to respond to standard medical therapy. We aimed to analyze the effect of the operator's learning curve in our center in terms of the safety of intracranial angioplasty and stenting.
METHODS: In this retrospective study, we analyzed patients treated with intracranial angioplasty and stenting in our center between January 2007 and December 2015. The endpoint was peri-procedure complications within 30 days. A risk-adjusted cumulative sum chart was used for the learning curve analysis. Multivariable logistic analysis was also used to evaluate the effect of the learning curve on intracranial angioplasty and stenting.
RESULTS: A total of 329 patients were included. The overall peri-procedure complication rate was 8.21% (27/329). Multivariate logistic regression analysis showed that operators with experience of >20 cases [odds ratio (OR) =0.229; 95% confidence interval (CI): 0.059-0.893] and >40 cases (OR =0.024; 95% CI: 0.006-0.093) were associated with a low risk of complications compared with operators with experience of ≤20 cases. Furthermore, patients with hypertension (OR =3.595; 95% CI: 1.104-11.702) and stenosis of Mori classification C (OR =28.562; 95% CI: 4.788-170.395) were associated with a high risk of complications. The observed outcome was better than expected (more negative deflections) after the 30th consecutive case.
CONCLUSIONS: The level of operator experience can influence the risk of peri-procedure complications associated with intracranial angioplasty and stenting. A total of 30 consecutive cases is required for an operator to overcome the learning curve.

Entities:  

Keywords:  Complications; intracranial angioplasty and stenting; learning curve

Year:  2018        PMID: 30364053      PMCID: PMC6186977          DOI: 10.21037/atm.2018.08.08

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  13 in total

1.  Learning curve for intracranial angioplasty and stenting in single center.

Authors:  Qiankun Cai; Yongkun Li; Gelin Xu; Wen Sun; Yunyun Xiong; Wenshan Sun; Yuanfei Bao; Xianjun Huang; Yao Zhang; Lulu Zhou; Wusheng Zhu; Xinfeng Liu
Journal:  Catheter Cardiovasc Interv       Date:  2013-07-01       Impact factor: 2.692

2.  China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.

Authors:  Peng Gao; Zhenwei Zhao; Daming Wang; Jian Wu; Yiling Cai; Tianxiao Li; Wei Wu; Huaizhang Shi; Weiwen He; Fengshui Zhu; Liqun Jiao; Feng Ling
Journal:  Interv Neuroradiol       Date:  2015-05-01       Impact factor: 1.610

Review 3.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Authors:  Chirantan Banerjee; Marc I Chimowitz
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

4.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

5.  Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.

Authors:  Yongjun Wang; Xingquan Zhao; Liping Liu; Yannie O Y Soo; Yuehua Pu; Yuesong Pan; Yilong Wang; Xinying Zou; Thomas W H Leung; Yefeng Cai; Qingke Bai; Yiping Wu; Chunxue Wang; Xiaoping Pan; Benyan Luo; Ka Sing Lawrence Wong
Journal:  Stroke       Date:  2014-01-30       Impact factor: 7.914

6.  Angioplasty and stenting for intracranial atherosclerotic stenosis with nitinol stent: factors affecting technical success and patient safety.

Authors:  Simon Chun Ho Yu; Thomas Wai Hong Leung; Esther Hiu Yee Hung; Kwok Tung Lee; Lawrence Ka Sing Wong
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

7.  Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis.

Authors:  S G Zhu; R L Zhang; W H Liu; Q Yin; Z M Zhou; W S Zhu; Y L Zhu; G L Xu; X F Liu
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-06-15       Impact factor: 7.069

8.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245

9.  Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results.

Authors:  W-J Jiang; X-T Xu; M Jin; B Du; K-H Dong; J-P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

10.  Wingspan stenting can effectively prevent long-term strokes for patients with severe symptomatic atherosclerotic basilar stenosis.

Authors:  Wei-Xing Bai; Bu-Lang Gao; Tian-Xiao Li; Zi-Liang Wang; Dong-Yang Cai; Liang-Fu Zhu; Jiang-Yu Xue; Zhao-Shuo Li
Journal:  Interv Neuroradiol       Date:  2016-01-27       Impact factor: 1.610

View more
  1 in total

1.  Endovascular Therapy for Intracranial Artery Stenosis: Results from the Japanese Registry of Neuroendovascular Therapy (JR-NET)3.

Authors:  Takashi Izumi; Masahiro Nishibori; Hirotoshi Imamura; Koji Iihara; Nobuyuki Sakai
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-04-15       Impact factor: 1.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.